CALC

Healthcare Biotechnology

CalciMedica, Inc.

$1.60

-0.02 -1.35% today

Price History

Not enough data

Key Stats

Market Cap

10.93M

Avg Volume

73,388

EPS

-$6.85

52W High

$36.00

52W Low

$1.58

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-0.98

P/B Ratio

1.78

EV/EBITDA

-0.08

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(365.7%)

Return on Assets

(63.6%)

Liquidity & Leverage

Current Ratio

5.58

Quick Ratio

5.33

Debt / Equity

1.67

Total Cash

18.62M

Total Debt

9.20M

About

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.

calcimedica.com